-+ 0.00%
-+ 0.00%
-+ 0.00%

HC Wainwright & Co. Assumes Humacyte at Buy, Announces Price Target of $4

Benzinga·05/14/2025 18:03:28
Listen to the news
HC Wainwright & Co. analyst Swayampakula Ramakanth assumes Humacyte (NASDAQ:HUMA) with a Buy rating and announces Price Target of $4.